Charles River Laboratories | CRL - Ebitda





Ebitda Veränderung Datum
Agilent USD 577M 77M 2026-06
Align Technology USD 229.14M 31.74M 2026-03
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Cardinal Health USD 955M 135M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Cigna USD 3.28B 416M 2026-03
CVS Health USD 5.85B 25M 2026-06
Danaher USD 1.84B 81M 2026-06
Dentsply International USD 190M 61M 2026-06
Elevance Health USD 4.21B 2.02B 2026-03
Humana USD 2.06B 2.35B 2026-03
Illumina USD 330M 80M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Intrexon USD -24.7M 2.92M 2024-06
IQVIA Holdings USD 994M 62M 2026-06
Laboratory Of America USD 767.7M 162.1M 2026-06
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
McKesson USD 1.71B 674M 2026-06
Merck EUR 1.6B 69M 2026-06
Mettler Toledo International USD 322.64M 43.66M 2026-06
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 6.01B 18M 2026-06
Quest Diagnostics USD 648M 91M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Thermo Fisher Scientific USD 3.55B 845M 2026-06
United Therapeutics USD 355M 11.1M 2026-06
UnitedHealth USD 9.43B 567M 2026-06
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 712M 545M 2026-06
West Pharmaceutical Services USD 243.6M 17.4M 2026-06